Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0000950170-24-130754

CEO bought 26,500 shares at an average $3.79 ($100,468)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Spoor Johan M. CEO 2024-11-25 Purchase +14,500 $3.78 $54,868 152,072 D
Spoor Johan M. CEO 2024-11-25 Purchase +5,400 $3.80 $20,520 5,400 I
Spoor Johan M. CEO 2024-11-25 Purchase +6,600 $3.80 $25,080 66,600 I
Open-market purchases · 26,500 sh · avg $3.79 · $100,468
Loading xslF345X05/ownership.xml…